GLOBAL CANCER INITIATIVES
14 CANCER CONTROL 2021
interests are prevention, preventive strategies, social inequalities,
antimicrobial resistance and a whole of society approach to public
health. She is an intensive care nurse by education.
Jon Kirknes is Head of Department for Cancer Research and
Prevention at the Norwegian Cancer Society. Previously he headed
the section for cancer care. He has wide experience in political
advocacy, organizational development and leadership. Jon is also
board member at Gemini Centre for Sepsis Research.
Anna Zorzet has a PhD in Medical Microbiology with a focus on
antibiotic resistance from Uppsala University. She has been working
for the global network ReAct - Action on Antibiotic Resistance since
2011. She was Director of ReAct Europe for 7 years and now serves
as a strategic adviser. Anna is also a member of the UICC Task Force
sustainable supply of medicines and diagnostics (existing and
new) for cancer patients, especially in LMICs.
Against this background a more in-depth discussion on
access to antimicrobials for cancer patients will take place
during the forthcoming 3rd LGCW in November 2021. The
focus of this session will be access to medicines and diagnostics.
Taking forward the messages from LGCW 2020, speakers at
this session will elaborate on and provide insight into possible
partnerships in ensuring equitable access to treatments
globally. The session is once again a partnership between UICC,
the Wellcome Trust, the Norwegian Cancer Society and will
include UICC task force members, SIOP and ReAct along with
insights from the industry. n
Research areas that need urgent attention and
J Strengthening surveillance capacity to ensure quality data
on the impact of AMR.
J Evidence generation on the impact of AMR on cancer care
J Evidence-based resources to increase knowledge and
awareness on AMR across communities to influence policy
J Ensuring equitable access to novel therapies.
Shalini Jayasekar Zürn is a senior advocacy manager with the
Union for International Cancer Control (UICC). She is a biologist
by training and has extensive experience on the issues of access to
quality-assured medicines. Shalini gained experience in this topic
by working with the World Health Organization on their Model List
of Essential Medicines as well as Médecins Sans Frontières's access
campaign and other NGOs. She also has experience working with
the pharmaceutical industry.
Sonali Johnson is Head of Knowledge, Advocacy and Policy at
the Union for International Cancer Control (UICC). Her main area
of work is to ensure that cancer prevention, treatment, and care
is positioned within the global health and development agenda,
including plans for universal health coverage (UHC). During her
professional career, Sonali has worked on a range of public health
issues including cancer control, gender and HIV/AIDS, reproductive
and sexual health, gender based violence, knowledge translation,
research ethics and health and human rights.
Sonali holds a PhD and post-doctorate diploma in public health
and policy from the London School of Hygiene and Tropical Medicine
and an MSc in Gender and Development from the London School of
Economics and Political Science.
Carina Alm is a special adviser at the Norwegian Cancer Society
working in the field of noncommunicable diseases (NCDs). Her special